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A balanced approach to interpreting 
the WHIRCDMT
To the Editor: I read with interest the critique of the Women’s 
Health Initiative Randomized Controlled Dietary Modification Trial 
(WHIRCDMT)[1] by Prof. Tim Noakes.[2] His critique focused on the 
varying incidence of cardiovascular outcomes between women with 
and without a history of cardiovascular disease (CVD), and justly 
called for more discussion and transparency with respect to these 
findings. The latter half of the critique, however, unfairly portrays 
the low-fat dietary intervention as deleterious for weight gain and the 
development of diabetes mellitus (DM). 
First, Prof. Noakes should be applauded for raising awareness 
around what many researchers and clinicians would characterise as the 
disappointing findings of the WHIRCDMT. Additionally, his discussion 
on the potentially negative effects of a low-fat diet in women with 
prior history CVD or DM is illuminating. Evidence from other studies 
supports the idea that reducing dietary fat without paying attention to the 
composition of foods substituting it can have deleterious effects.[3] 
Several of the criticisms of the WHIRCDMT, however, were 
exaggerated or misleading. Specifically, Prof. Noakes states that for 
women randomised to the intervention group, ‘the leanest women 
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at the start of the trial gained weight on the low-fat diet’.[2] While the 
leanest women in the intervention group did indeed gain weight, this 
was also true for the leanest women in the control group.[4] In fact, 
women in the intervention group had significantly lower weight than 
those in the control group among women with a body mass index 
<25 kg/m2 at baseline.[4] May this result simply reflect that the leanest 
women were more susceptible to weight gain, regardless of assigned 
diet? It is important to remember that this trial was conducted 
at the same time that prevalence of obesity in the US increased,[5] 
and increases in weight for a proportion of participants would be 
expected due to myriad changes in the environment.  
A second issue with Prof. Noakes’ critique is the statement that, ‘those 
with the least insulin resistance at the start of the trial were at greater 
risk of developing type 2 DM if assigned to the low-fat diet’.[2] He is 
correct that there was a significant interaction between intervention 
assignment and glycaemic control markers (insulin and homeostasis 
model assessment, insulin resistance).[6] In truth, however, there were 
no detectable differences between individual tertiles,[6] which limits the 
ability to make causative statements regarding subgroups. What is more, 
the absolute counts in the lowest tertiles were extremely small, mostly 
because data on glycaemic measures were available for only 2 816/45 887 
participants.[6] Moreover, the true significance of any subgroup analysis 
should be viewed with scepticism. In effect, these analyses remove the 
protection from confounding that randomisation provides, and unless 
subgroup analyses are done only on a few, pre-specified endpoints, 
they can lead to erroneous conclusions.[7] Thus, Prof. Noakes’ statement 
seems, at a minimum, overly confident regarding the effects of a low-fat 
dietary intervention for the primary prevention of DM.
Prof. Noakes’ critique of the WHIRCDMT highlights several issues 
with the prescription of a low-fat diet, including the variability of 
effectiveness for different groups in the population. In particular, 
individuals with pre-existing CVD and DM may experience harmful 
effects when attempting to follow a low-fat diet. Nevertheless, the 
WHIRCDMT does not provide high-quality evidence that a low-
fat diet emphasising fruits, vegetables and whole grains contributes 
disproportionately to the development of DM and weight gain.   
While it can be agreed the WHIRCDMT was disappointing in 
many ways for researchers and clinicians alike, a more balanced 
approach to the interpretation of the results is warranted. 
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